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Abstract
Neither expression nor functionality is clear in peripheral
tissues with the molecular machineries required for exci-
tatory neurotransmitter signaling by -glutamate (Glu) in
the central nervous system, while a recent study has shown
that several Glu receptors are functionally expressed in the
rat testis. This fact prompted us to explore the possible
functional expression in the rat testis of the Glu trans-
porters usually responsible for the regulation of extracel-
lular Glu concentrations in the brain. RT-PCR revealed
the expression, in the rat testis, of mRNA for five diﬀerent
subtypes of Glu transporters, in addition to that for
particular subtypes of ionotropic and metabotropic Glu
receptors. Glutamate transporter-1 (GLT-1) was diﬀerent
in the brain from that in the testis in terms of molecular
sizes on Northern and Western blot analyses. In situ
hybridization as well as immunohistochemical analysis
showed localized expression of glutamate aspartate trans-
porter at interstitial spaces and GLT-1 at elongated sper-
matids in the rat testis respectively. The expression of
mRNA was localized for excitatory amino acid
transporter-5 at the basal compartment of the seminiferous
tubule in the rat testis. [3H]Glu was accumulated in
testicular crude mitochondrial fractions in a temperature-
and sodium-dependent saturable manner with pharmaco-
logical profiles similar to those shown in brain crude
mitochondrial fractions. These results suggested that
particular subtypes of central Glu transporters for the
regulation of extracellular Glu concentrations in the rat
testis could be constitutively and functionally expressed.
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Introduction
-Glutamate (Glu) is believed to play an excitatory amino
acid neurotransmitter role through particular molecular
machineries required for signaling processes in the central
nervous system (CNS). These include Glu receptors
(GluRs) for signal input, vesicular Glu transporters
(VGLUTs) for signal output and Glu transporters (GluTs)
for signal termination. In the CNS, extracellular Glu could
contribute to the mechanism associated with synaptic
plasticity, with neurotoxicity at an excessive level. GluTs
are required for the termination of signal transduction
mediated by Glu as well as for the prevention of neuro-
toxicity mediated by this endogenous excitotoxin. These
transporters sometimes maintain a 10 000-fold gradient of
intracellular Glu (3–10 mM) to extracellular Glu (0·3–
1 µM), which is driven by the ionic gradients generated
by ion-exchanging pumps such as Na+/K+-ATPase
(Schousboe & Divac 1979, Danbolt 2001). To date, GluTs
have been classified into five diﬀerent subtypes, includ-
ing glutamate aspartate transporter (GLAST) (excitatory
amino acid transporter 1; EAAT1), glutamate
transporter-1 (GLT-1) (EAAT2), excitatory amino acid
carrier (EAAC1, EAAT3), EAAT4 and EAAT5 (Danbolt
2001). Both GLAST and GLT-1 are found primarily in
glia cells, while EAAC1 is widely distributed in neurons.
EAAT4 and EAAT5 are selectively expressed in the
cerebellum and retina respectively. All these GluTs are
coupled to the electrochemical gradient of sodium ions
across cell membranes, with co-transport of one proton
molecule and counter-transport of one potassium molecule
(Danbolt 2001).
There is accumulating evidence in the literature for the
expression of particular subtypes of GluRs and GluTs
outside the CNS. In bone, for instance, both in situ
hybridization and immunohistochemical analyses have
revealed the expression of GLAST in both osteoblasts and
osteoclasts (Mason et al. 1997, Huggett et al. 2000), in
addition to the expression of various subunits and subtypes
of ionotropic GluRs (iGluRs) (Chenu et al. 1998, Patton
et al. 1998) and metabotropic GluRs (mGluRs) (Gu &
Publicover 2000, Hinoi et al. 2001, 2002b). In adrenal
glands expressing mRNA for particular subunits of iGluRs
(Hinoi et al. 2002a), moreover, the expression of GLAST
has been shown on Northern and Western blot analyses
(Lee et al. 2001). GluTs could therefore play a role as the
molecular machinery responsible for either the termination
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of signal transduction or the prevention of toxicity medi-
ated by extracellular Glu in bone and adrenal glands as well
as in the CNS.
In the rat testis, mRNA and the corresponding proteins
are constitutively and functionally expressed for both
mGluR1 and mGluR5, but not for mGluR2 and
mGluR3 (Storto et al. 2001). An agonist for group
I mGluR subtype markedly facilitates hydrolysis of inositol
phospholipid in slices of rat testis (Storto et al. 2001).
Immunohistochemical and molecular biological analyses
have revealed the expression of NMDA receptor (NR1) in
germinal epithelium and interstitial spaces, GluR2/3 in
interstitial spaces, mGluR2/3 proteins in interstitial cells
and the wall of arterioles, mGluR1 in Sertoli cells and
mGluR5 in germinal cells except spermatogonia (Gill et al.
2000, Storto et al. 2001). For signal transduction mediated
by Glu in the testis, however, Glu should be incorporated
in adjacent cells for the termination of Glu signals through
GluTs with high aﬃnity, in addition to the receptor
system as described above. A Northern blot study has
shown expression of mRNA for a novel GluT later found
to be identical to GLAST (Storck et al. 1992, Danbolt
2001) in rat forebrain, cerebellum and testis (Tanaka
1993). Expression of mRNA has also been shown for the
neuron-specific glutamate aspartate transporter isolated
from human brain cDNA libraries in human brain,
liver, muscle, ovary and testis on Northern blot analysis
(Shashidharan et al. 1994). In order to elucidate a possible
role of Glu as a signal mediator in the testis, therefore, we
have attempted to examine the possible expression and
localization of particular subtypes of GluTs, in addition to




[-32P]dCTP (111 TBq/mmol) and [3H]-Glu (1587·3
GBq/mmol) were purchased from Perkin Elmer Life
Sciences (Boston, MA, USA). Guinea pig polyclonal
antibodies against GLAST (carboxy terminus) and GLT-1
(carboxy terminus) were obtained from CHEMICON
International (Temecula, CA, USA). A rabbit anti-rat
EAAT4 antibody (carboxy terminus) was purchased from
Alpha Diagnostic International (San Antonio, TX, USA).
A biotinylated anti-guinea pig IgG antibody and
VECTASTAIN Elite ABC Reagent were provided by
Vector Laboratories (Burlingame, CA, USA). QuickPrep
Micro mRNA Purification Kit, Ready-To-Go You-
Prime First-Strand Beads, anti-guinea pig IgG antibody
conjugated with horseradish peroxidase, ECL detection
reagent and Rediprime II random prime labeling system
were supplied by Amersham Biosciences (Piscataway, NJ,
USA). Taq polymerase was obtained from Takara (Shiga,
Japan). ISOGEN, -glutamate, -aspartate and kainic
acid (KA) were purchased from Wako (Osaka, Japan).
Quantum Prep Freeze ‘N Squeeze DNA Gel Extraction
Spin Columns and Bio-Rad Protein Assay Kit were
provided by Bio-Rad Laboratories (Hercules, CA, USA).
Lig’nScribe No-Cloning Promoter Addition Kit was
supplied by Ambion (Austin, TX, USA). Digoxigenin
(DIG) RNA Labeling Kit (SP6/T7) and anti-DIG-
AP Fab fragments were obtained from Roche Diag-
nostics (Mannheim, Germany). -trans-pyrrolidine-2,4-
dicarboxylic acid (PDC), -()-threo-3-hydroxyaspartic
acid (THA), (2S,1S,2R)-2-(carboxycyclopropyl)glycine
(CCGIII), N-methyl--aspartic acid (NMDA), DL-
-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA), (RS)-3,5-dihydroxyphenylglycine (DHPG), (2S,
2R,3R)-2-(2,3-dicarboxycyclopropyl)glycine (DCGIV)
and -(+)-2-amino-4-phosphonobutyric acid (L-AP4)
were purchased from Tocris (Bristol, UK). Other chemicals
used were all of the highest purity commercially available.
Whatman GF/B glass fibre filter was obtained from
Whatman (Clifton, NJ, USA).
Animals
The protocol employed in this study meets the guideline
for animal experimentation of the Japanese Society for
Pharmacology and was approved by the Committee
for Ethical Use of Experimental Animals at Kanazawa
University. All eﬀorts were made to minimize animal
suﬀering, to reduce the number of animals used, and to
utilize alternatives to in vivo techniques. Male Wistar rats
at 7 weeks of age were purchased from a local supplier and
housed in our bleeding rooms at 25 C with a humidity of
55% and a light:darkness cycle of 12 h, with free access to
water and food.
RT-PCR
Each tissue was subjected to extraction of mRNA using
the QuickPrep Micro mRNA Purification Kit, followed
by the synthesis of DNA with 12·5 µM random hexamer
primers and Ready-To-Go You-Prime First-Strand Beads
as described previously (Hinoi et al. 2001). A reaction with
reverse transcriptase was run at 37 C for 1 h, and an
aliquot of synthesized cDNA was used directly for PCR
conducted in buﬀer containing 10 mM Tris–HCl (pH
8·3), 50 mM KCl, 1·5 mM MgCl2, 200 µM of each
dNTP, 20 pmol of each primer and 0·625 units Taq
polymerase. Cycling conditions used for 40 PCR cycles
were as follows: GLAST, GLT-1, EAAC1, EAAT4 and
EAAT5, denaturation for 45 s at 95 C, annealing for 40 s
at 64 C and extension for 40 s at 72 C. Electrophoresis
was run for an aliquot of PCR amplification products on a
2% agarose gel, followed by detection of DNA with
ethidium bromide. Appropriate PCR DNA products were
extracted from agarose gel using DNA extraction spin
columns, followed by sequencing by ABI Prism 310
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Genetic Analyzer (Perkin Elmer) using a cycle sequencing
kit.
Western blotting
Each tissue was homogenized in 10 mM HEPES–NaOH
buﬀer (pH 7·9) containing 10 mM KCl, 1 mM EDTA,
1 mM EGTA, 5 mM dithiothreitol, 10 mM sodium
fluoride, 10 mM sodium -glycerophosphate and
1 µg/ml of each protease inhibitor ((p-amidinophenyl)
methanesulfonyl fluoride, benzamidine, leupeptine, an-
tipain), followed by centrifugation at 800 g for 10 min.
Supernatants were centrifuged at 20 000 g for 20 min, and
the resultant supernatants were centrifuged at 100 000 g
for 60 min. The pellets thus obtained (P3 fractions) were
suspended in the aforementioned buﬀer and the suspen-
sions were mixed at a volume ratio of 4:1 with 10 mM
Tris–HCl buﬀer (pH 6·8) containing 10% glycerol, 2%
SDS, 0·01% bromophenol blue and 5% mercaptoethanol,
followed by boiling at 100 C for 10 min. Each aliquot of
0·2 or 20 µg protein was subjected to electrophoresis on a
10% polyacrylamide gel at a constant current of 15 mA/
plate for 2 h at room temperature and subsequent blotting
to a polyvinylidene fluoride membrane previously treated
with 100% methanol. After being blocked by 5% skimmed
milk dissolved in 20 mM Tris–HCl buﬀer (pH 7·5)
containing 137 mM NaCl and 0·05% Tween 20 (TBST),
the membrane was incubated with guinea pig polyclonal
antibodies against GLAST (1:8000 dilution) and GLT-1
(1:4000 dilution) or rabbit polyclonal antibody against
EAAT4 (1:1600 dilution) diluted with TBST containing
1% skimmed milk, and then incubated with the anti-
guinea pig IgG antibody or the anti-rabbit antibody
conjugated with horseradish peroxidase. Finally, the
membrane was incubated with ECL detection reagent,
followed by exposure to X-ray films for diﬀerent periods
to obtain the most appropriate blots.
Northern blotting
Each tissue was subjected to extraction of total RNA using
the ISOGEN. An aliquot of total RNA (neocortex, 5 or
10 µg/lane; retina, 5 µg/lane; testis, 50 µg/lane) was sub-
jected to electrophoresis on a 1% denatured agarose gel
containing 2·2 M formaldehyde at a constant voltage of
50 V at room temperature and subsequently transferred to
a nylon membrane by capillary blotting. The blotted
membrane was previously hybridized with 5SSC
(750 mM NaCl, 75 mM sodium citrate) containing 50%
formamide, 5Denhardt’s, 0·5% SDS and 25 µg/ml
salmon sperm DNA at 42 C and then hybridized with
32P-radiolabeled fragments of the cDNA at 42 C for 16 h.
The cDNA probe was prepared by RT-PCR with
primers specific for GLT-1 or EAAT5, followed by
isolation of the amplified product on the gel and subse-
quent purification by Quantum Prep Freeze ‘N Squeeze
DNA Gel Extraction Spin Columns for radiolabeling with
[-32P]dCTP using the Rediprime II random prime
labeling system. The hybridized membrane was succes-
sively washed with 2SSC containing 0·1% SDS at room
temperature for 10 min twice, 1SSC containing 0·1%
SDS at 42 C for 20 min, and then 0·5SSC containing
0·1% SDS at 42 C for 20 min, followed by exposure to
X-ray films for diﬀerent periods to obtain the most
appropriate blots.
Preparation of DIG-labeled cRNA probe
The cDNA fragments were amplified using the PCR
procedures described above, followed by ligation reaction
with the T7 promoter adapter using the Lig’nScribe
No-Cloning Promoter Addition Kit. An aliquot of syn-
thesized T7 promoter-adapted cDNA was used directly for
PCR carried out in buﬀer containing 10 mM Tris–HCl
(pH 8·3), 50 mM KCl, 1·5 mM MgCl2, 200 µM of
each dNTP, 6·25 pmol PCR adapter primer (5-
GCTTCCGGCTCGTATGTTGTGTGG-3) and gene
specific primer (to produce the antisense (sense) cRNA
probe, 5 (3) gene specific primer) and 1·25 units Taq
polymerase. The cycling conditions used were as follows:
30 cycles of 30 s at 94 C for denaturation, 30 s at 57 C for
annealing and 1 min at 72 C for extension. Subsequently,
to produce DIG-labeled cRNA, amplified T7 promoter-
adapted cDNA was transcribed by T7 RNA polymerase
according to the manufacturer of the DIG RNA Labeling
Kit (SP6/T7). The DIG-labeled cRNA was stored at
20 C until use.
In situ hybridization
Testes were removed from male Wistar rats, followed by
rapid freezing on crushed dry ice and subsequent dissec-
tion of sections at a thickness of 10 µm in a cryostat at
20 C. These sections were fixed with 4% paraformal-
dehyde in 0·1 M phosphate buﬀer (PB, pH 7·4) for
20 min, followed by washing three times with 0·1 M PB,
treating with 0·2 M HCl for 10 min, washing three times
with 0·1 M PB, treating with 10 µg/ml proteinase K
for 5 min and washing three times with 0·1 M PB.
Sections were then subjected to acetylation in 0·1 M
triethanolamine/0·25% acetic anhydride for 10 min,
followed by washing with 0·1 M PB and stepwise
dehydration in 70, 80, 90, 95 and 100% ethanol for 5 min
each. After being dried, sections were covered with the
hybridization buﬀer (10% dextran sulfate, 5SSC,
20 mM Tris–HCl (pH 8·0), 300 mM NaCl, 50% forma-
mide, 1Denhardt’s and 500 µg/ml yeast tRNA) con-
taining 25 µg/ml salmon sperm DNA at 65 C for 1 h, and
then incubated with hybridization buﬀer containing
the DIG-labeled cRNA probe at 65 C for 16 h. Post-
hybridization washes were done stepwise with 4SSC at
65 C for 20 min, 50% formamide in 2SSC at 65 C for
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30 min, TNE buﬀer (10 mM Tris–HCl (pH 7·5), 1 mM
EDTA and 500 mM NaCl) at 37 C for 10 min three
times, 4 µg/ml RNase A in TNE buﬀer at 37 C for
30 min, TNE buﬀer at 37 C for 10 min, 2SSC at
65 C for 30 min, 0·2SSC at 65 C for 30 min, buﬀer 1
(100 mM Tris–HCl (pH 7·5) and 150 mM NaCl) at room
temperature for 10 min and then 1·5% blocking buﬀer
(1·5% blocking reagent in buﬀer 1) at room temperature
for 1 h. Subsequently, sections were washed with buﬀer 1
at room temperature, and then incubated with 0·75 U/ml
anti-DIG-AP Fab fragments in 0·5% blocking buﬀer
containing 0·2% Tween at 4 C for 16 h. After being
washed four times with buﬀer 1 containing 0·2% Tween at
room temperature for 15 min, sections were treated with
buﬀer 2 (100 mM Tris, 100 mM NaCl and 50 mM
MgCl2 (pH 9·5)) and then developed in buﬀer 2 contain-
ing 375 µg/ml nitro blue tetrazolium chloride and 188 µg/
ml 5-bromo-4-chloro-3-indolyl phosphate for diﬀerent
periods to obtain the most appropriate pictures. After
washing with buﬀer 2 at room temperature for 5 min, the
development was stopped by incubation in 1TE
(10 mM Tris–HCl (pH 7·5) and 1 mM EDTA (pH 8·0)).
Immunohistochemistry
Testes were removed from male Wistar rats, followed by
rapid freezing on crushed dry ice and subsequent dissec-
tion of sections at a thickness of 10 µm in a cryostat at
20 C. Sections were fixed with 4% paraformaldehyde
in phosphate-buﬀered saline (PBS) for 20 min, followed
by washing with PBS, treating with 0·3% H2O2 in
methanol for 30 min and washing with 70% ethanol for
5 min. After being washed with PBS, sections were
subjected to blocking with PBS containing normal goat
serum and 0·1% Triton X-100 at room temperature for
1 h. Sections were then reacted with antibodies against
GLAST (1:500 dilution) and GLT-1 (1:400 dilution)
diluted with the same blocking buﬀer at room temperature
for 1 h, followed by reaction with biotinylated anti-guinea
pig IgG antibody at room temperature for 30 min and
subsequent incubation with VECTASTAIN Elite ABC
Reagent at room temperature for 1 h. Finally, immuno-
staining was carried out using 0·05% diaminobenzidine
and 0·01% hydrogen peroxide using hematoxylin as the
counterstain.
[3H]Glu uptake assay
For evaluation of the functionality of the GluTs expressed,
an attempt was made to determine whether rat testis
indeed has the ability to accumulate radiolabeled substrate
in a temperature-dependent saturable manner. Testes
obtained from male Wistar rats at 7 weeks of age were
rapidly homogenized in 0·32 M sucrose and homogenates
were centrifuged at 800 g for 20 min. The resultant
supernatants were centrifuged at 20 000 g for 20 min. The
pellets thus obtained (P2) were suspended in 0·32 M
sucrose and centrifuged at 20 000 g for 20 min again.
These washing procedures were repeated three times, and
the final pellets were suspended in HEPES buﬀer
(125 mM NaCl, 3·5 mM KCl, 1·5 mM CaCl2, 1·2 mM
MgSO4, 1·25 mM KH2PO4, 25 mM NaHCO3, 10 mM
HEPES and 10 mM -glucose (pH 7·4)) for use in the
uptake experiments (Takarada et al. 2003). Membrane
suspensions were preincubated for 5 min at 2 C or 30 C,
followed by incubation with 10 nM [3H]-Glu for
1–60 min. For pharmacological analysis, test compounds
were introduced into the incubation medium at the
beginning of the preincubation. The incubation was
terminated by the addition of ice-cold buﬀer at 2 C and
subsequent filtration through a Whatman GF/B glass fiber
filter under constant vacuum. The filter was rinsed four
times with ice-cold buﬀer at 2 C, and the radioactivity
retained on the filter was measured using a liquid scintil-
lation spectrometer. Assays were always carried out in
triplicate with variations of less than 10%. Protein concen-
tration was determined with Bio-Rad protein.
Data analysis
Results are all expressed as the meansS.E. and statistical
significance was determined by two-tailed and unpaired




Figure 1a shows the nucleotide sequences of the primers
used for the demonstration of expression of mRNA for
iGluRs, mGluRs and GluTs in this study. Tissue samples
were homogenized, followed by extraction of mRNA and
subsequent RT-PCR using one of these primers. Figure
1b shows profiles of the expression of mRNA for five
diﬀerent GluTs cloned to date in diﬀerent tissues of the rat
on RT-PCR. GLAST mRNA was expressed in rat
neocortex, testis, ovary, pancreas and stomach but not in
intestine, while GLT-1 mRNA was invariably expressed
in all tissues tested. Similarly, mRNA for both EAAC1
and EAAT4 was expressed in neocortex or cerebellum,
testis, ovary, pancreas, stomach and intestine. However,
mRNA was expressed for EAAT5 in both retina and testis
only, but not in other regions including ovary, pancreas,
stomach and intestine.
In rat whole brain, mRNA was expressed for all iGluR
subtypes tested (Fig. 1c). These included NR1, NR2A–C
and NR2D subunits for NMDA receptors, GluR1–4 and
GluR5 subunits for AMPA receptors, and GluR6, GluR7,
KA1 and KA2 subunits for KA receptors respectively. In
the rat testis, by contrast, mRNA was not expressed for
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either GluR5 or GluR6 subunits of KA receptors with
expression of mRNA for other iGluR subunits examined.
In rat whole brain or neocortex, mRNA was invariably
expressed for all mGluRs tested, including mGluR1 to
mGluR8 (Fig. 1d). Of the mGluRs examined, however,
mRNA was expressed for mGluR1 to mGluR6 and
mGluR8 but not for mGluR7 in rat testis. In particular,
two splicing variants were detected with mRNA for
Figure 1 RT-PCR analysis on GluTs and GluRs. (a) Nucleotide sequences of
primers used. mRNA was extracted from different tissues of the rat, followed by
RT-PCR using specific primers for (b) GluTs, (c) iGluRs and (d) mGluRs. The
experiments were repeated at least three times using different animals with
similar results. CX, neocortex; CL, cerebellum; RT, retina; T, testis; O, ovary; P,
pancreas; S, stomach; I, intestine; Br, whole brain.
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mGluR2 in rat testis in contrast to one single mGluR2
mRNA in rat whole brain.
Expression of GluTs
Rat neocortex, cerebellum and testis were homogenized
in buﬀer containing diﬀerent protease inhibitors, followed
by successive centrifugation to obtain microsomal (P3)
fractions, and subsequent SDS-PAGE for immunoblotting
analysis using commercially available antibodies against
GLAST, GLT-1 and EAAT4. Immunoreactivity was
found with GLT-1 (Fig. 2a, middle panel) in the rat
testis at a molecular weight position smaller than that for
the neocortex, but not with GLAST (Fig. 2a, left panel)
and EAAT4 (Fig. 2a, right panel), under the conditions
employed (Fig. 2a). Immunoblotting analysis using the
secondary antibody alone led to detection of weak
immunoreactivity at a position similar to cortical GLT-1
in the rat testis, but not in the neocortex (data not shown).
To further analyze the diﬀerence in molecular size of
GLT-1 between neocortex and testis on Western blot
analysis, Northern blot analysis was carried out using a
radiolabeled cDNA probe for GLT-1 mRNA. The
GLT-1 cDNA probe was prepared by RT-PCR with
primers specific for GLT-1, followed by isolation of
amplified product on the gel and subsequent purification
Figure 2 Western and Northern blot analyses on GluTs. (a) Microsomal (P3) fractions were prepared from each tissue, followed by
SDS-PAGE and subsequent detection of immunoreactive GLAST, GLT-1 and EAAT4. (b) Total RNA was extracted from each tissue,
followed by electrophoresis on agarose gel and subsequent incubation with [32P]labeled cDNA probe for GLAST, GLT-1 or EAAT5. The
experiments were repeated at least three times using different animals with similar results. CX, neocortex (0·2 g in (a)); CL, cerebellum
(0·2 g in (a)); T, testis (20 g in (a)); RT, retina.
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for radiolabeling with [-32P]dCTP using a labeling sys-
tem. Total RNA was extracted for Northern blot analysis
from rat neocortex and testis. As shown in Fig. 2b, a clearly
smaller size was seen with mRNA detected by the
radiolabeled cDNA probe for GLT-1 in total RNA
extracts from testis than those from neocortex detected as
an upper radioactive band at the position demonstrated
previously (Fig. 2b, middle panel), with a slightly smaller
size for GLAST mRNA in testis than in neocortex (Fig.
2b, left panel). By contrast, radioactive bands were found
at almost similar molecular size positions with mRNA for
EAAT5 between total RNA extracts prepared from retina
and testis (Fig. 2b, right panel).
Localization of GluTs
In Fig. 3a, a schematic representation is shown for the
histological characteristics of the testis. Rat testis was
removed, followed by dissection of frozen sections and
subsequent fixation with paraformaldehyde for detection
of histological localization using DIG-labeled cRNA
probe. In situ hybridization evaluation clearly demon-
strated the localized expression of mRNA for GLAST
(Fig. 3b, left panels) at the interstitial space and for GLT-1
(Fig. 3b, second left panels) at the elongated spermatid in
the rat testis respectively (Fig. 3b). Further in situ hybrid-
ization analysis was carried out with cRNA probes
directed against other GluT subtypes including EAAC1,
EAAT4 and EAAT5 using frozen sections of rat testis.
Compared with negative control sections reacted with
individual sense cRNA probes, expression of EAAT5
mRNA was found in the basal compartment of semin-
iferous tubules in the rat testis (Fig. 3b, right panels), but
mRNA expression was not seen for EAAC1 and EAAT4
in the rat testis. However, specification of the exact
location of expression of mRNA for EAAT5 in the basal
compartment comprised of speramatocytes, Sertoli cells
and spermatogonia in the rat testis was not accomplished.
In order to confirm the localized expression of particular
subtypes of GluTs in rat testis, immunohistochemical
analysis was next made using commercially available
antibodies against GLAST and GLT-1 on frozen sections
of rat testis. A similar localization profile was seen with
immunoreactive GLAST in the interstitial space on im-
munohistochemistry using an antibody against GLAST in
the rat testis (Fig. 3c, left panels), while immunoreactive
GLT-1 was also found at elongated spermatids in the
rat testis as seen on in situ hybridization (Fig. 3c. right
panels).
[3H]Glu uptake
In order to elucidate a part of the functionality of the
GluTs expressed, an attempt was next made to determine
whether rat testis is really able to incorporate a substrate in
a temperature-dependent saturable manner as seen in the
brain. Rat testes were homogenized, followed by prep-
aration of crude mitochondrial fractions and subsequent
determination of the accumulation of [3H]Glu using a
rapid filtration method. The accumulation of [3H]Glu
rapidly increased with incubation time at 30 C in a
temperature-dependent manner and reached a plateau
within 30 min (Fig. 4a). Elevation of incubation tempera-
ture from 2 C to 30 C more than doubled the accumu-
lation of [3H]Glu when determined at 60 min, while the
accumulation also increased with incubation time even at
2 C, with a plateau within 30 min.
Rat testicular fractions were incubated with [3H]Glu in
buﬀer containing diﬀerent compounds at 10–100 µM at
30 C for 50 min. [3H]Glu accumulation was inhibited by
-Glu, -Asp, -Asp, PDC, THA and CCGIII in a
concentration-dependent manner at a concentration range
of 10–100 µM, with no significant inhibition by -Glu,
NMDA, AMPA, KA, DHPG, DCGIV, L-AP4 and
-alanine at 100 µM (Fig. 4b). Rat testicular fractions were
incubated with diﬀerent concentrations of [3H]Glu at
concentrations of up to 30 µM at 30 C for 10 min for
determination of saturation isotherms. The accumulation
increased with increasing concentrations of [3H]Glu fol-
lowed by saturation at 30 µM (Fig. 4c). Woolf–Hanes plot
analysis on [3H]Glu accumulation in rat testicular fractions
revealed a single component with a Km value of
24·24·4 µM and a Vmax value of 85·712·8 pmol/mg
protein per min respectively (Fig. 4d).
In order to confirm the net incorporation of radiolabeled
substrate, membrane fractions were treated with 0·01%
Triton X-100 and then incubated with [3H]Glu at 30 C
for 50 min. As shown in Fig. 4e, [3H]Glu accumulation
was significantly reduced to the level found at 2 C in rat
testicular fractions previously treated with Triton X-100.
For evaluation of sodium dependency, rat testicular frac-
tions were incubated with [3H]Glu at 30 C for 50 min in
HEPES buﬀer with replacement of NaCl by equimolar
ChCl. As shown in Fig. 4f, replacement of sodium
chloride with choline chloride significantly decreased
[3H]Glu accumulation in rat testicular fractions to the level
found at 2 C.
Discussion
The essential importance of the present findings was that
both mRNA and the corresponding proteins are expressed
for GLAST and GLT-1 with high localization at particular
individual locations in the rat testis. Testicular preparations
also exhibited the ability to accumulate [3H]Glu in a
temperature- and sodium-dependent saturable manner
with pharmacological profiles peculiar to GluTs in the
CNS. A previous Northern blot study has demonstrated
the expression of mRNA for GLAST in the rat testis as
well as the brain, without specification of the exact
location (Tanaka 1993). In the present study, moreover,
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Figure 3 Analyses on the localization of GluTs in the rat testis. (a) Schematic representation of the histological characteristics of
the testis. Rat testicular frozen sections were fixed with paraformaldehyde and then incubated with (b) DIG-labeled cRNA probe
for in situ hybridization on GLAST, GLT-1, EAAC1, EAAT4 and EAAT5 or (c) antibodies against GLAST and GLT-1 for
immunohistochemistry. Sections were stained with hematoxylin afterwards as needed. Typical micrographs are shown with similar
results in three independent experiments. Scale bars=100 m.
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Figure 4 Accumulation of [3H]Glu in rat testis. (a) Rat testis was homogenized and subjected to incubation with [3H]Glu at 2 C or
30 C for different periods up to 60 min. (b) Rat testicular fractions were incubated with [3H]Glu at 30 C for 50 min in buffer
containing each compound at 10 M (shaded bars) to 100 M (solid bars). (c) [3H]Glu accumulation was measured at substrate
concentrations of 0·01, 0·1, 1, 3, 10 and 30 M at 30 C for 10 min. (d) Woolf plot of the data obtained from the experiment shown in
(c). (e) Rat testicular fractions were treated with 0·01% Triton X-100, followed by determination of [3H]Glu accumulation at 30 C for
50 min. (f) Rat testicular fractions were incubated with [3H]Glu at 30 C for 50 min in the presence of 125 mM NaCl or ChCl. All values
shown are the meansS.E. obtained in three separate experiments done in triplicate. **P,0·01 significantly different from the individual
control values.
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the expression was shown with mRNA for GLT-1,
EAAC1, EAAT4 and EAAT5 in rat testis on RT-
PCR. To our knowledge, this paper deals with the first
direct demonstration of the expression of mRNA for all
GluT subtypes cloned to date in the rat testis. The
paradoxical detection of GLAST between Western and
immunohistochemical analyses could be accounted for by
taking into consideration the diﬀerential sensitivities of the
experimental procedures employed for detection, in ad-
dition to the localized expression of the protein concerned.
Western blot assay seems less sensitive than immunohis-
tochemistry at detecting a particular antigenic protein
expressed in a small amount at a localized and restricted
area in the rat testis as shown here. A similar paradox is
seen for the expression of EAAT4 on RT-PCR, Western
blot and in situ hybridization analyses in the present
study. Comprehensive evaluation would be required for
the identification and demonstration of a particular sub-
type of GluRs, GluTs and/or VGLUTs expressed in a
particular organ. One of the interesting findings obtained
in this study was the expression of mRNA for EAAT5,
which has been believed to be specifically localized in the
retina (Danbolt 2001) and in the rat testis on RT-PCR,
Northern blot and in situ hybridization analyses. Commer-
cial availability of an antibody against EAAT5 is therefore
a determinant of the promotion and stimulation of basic
and clinical research on this GluT subtype in future
studies.
Evidence is emerging for a role of Glu as an extracellular
signal mediator in the autocrine and/or paracrine system,
in addition to an excitatory amino acid neurotransmitter
role in the CNS (Skerry & Genever 2001). By analogy
with neurotransmission in the central glutamatergic syn-
apses, the expression of GluTs could be essential for the
termination of Glu signals through reduction of the
extracellular concentration in mechanisms underlying
possible signal transduction mediated by Glu in the testis.
In the CNS, GluTs are also required for attenuation of
neurotoxic properties of Glu as an endogenous excitotoxin.
Whether Glu is toxic to testicular cells as seen in central
neurons, however, remains to be elucidated. From this
point of view, it should be noted that exposure to
-aspartate selectively stimulates testosterone synthesis
after incorporation into cells, with that to - and -Glu,
-aspartate and - and -aspargine being ineﬀective, in
cultured rat Leydig cells (Nagata et al. 1999). Nagata et al.
(1999) have also claimed expression of GLAST mRNA in
rat Leydig cells without providing any direct evidence. In
the present study, by contrast, highly localized expression
of both mRNA and the corresponding protein for GLAST
in the testicular interstitial space where Leydig cells are
enriched in addition to both blood vessels and macro-
phages has been shown for the first time. Our data from
in situ hybridization and immunohistochemical analyses
are thus in good agreement with the report described
above. GLAST is highly enriched in astroglial cells in the
CNS (Danbolt 2001), whereas testicular Leydig cells are
shown to express glial fibrillary acidic protein which is a
marker protein of astroglia (Holash et al. 1993). In the
CNS, astroglia are shown to contribute to the blood–brain
barrier through extension of their foot processes onto
microvessels that constitute the physical entity, in addition
to secretion of a trophic factor to endothelial cells in
microvessels. Leydig cells would be, at least in part,
involved in the blood–testis barrier constituted by tight
junctions between Sertoli cells in seminiferous tubules as
well as by myoid cells through secretion of a trophic factor,
as seen with astroglial cells for the blood–brain barrier
(Holash et al. 1993).
In contrast to VGLUTs required for condensation of
Glu in synaptic vesicles, all GluTs cloned to date have
been shown to be unable to diﬀerentiate between optic
isomers of aspartate (Danbolt 2001). -Aspartate endogen-
ously occurs in rat adenohypophysis, testis, adrenal and
brain in a rank order of decreasing levels, while an
intraperitoneal injection of -aspartate induces a marked
increase in its endogenous levels in these neuroendocrine
tissues including the testis (D’Aniello et al. 2000). These
previous and present findings all give support to the idea
that testosterone synthesis could be facilitated by
-aspartate incorporated into intracellular locations
through GLAST expressed at Leydig cells in the testis.
The possibility that GluTs could play a role crucial for
signal transduction in mechanisms associated with inter-
cellular communications within the testis is feasible so far.
The present pharmacological evaluation failed to identify
the participation of particular GluT subtypes in [3H]Glu
accumulation in testicular mitochondrial fractions that
were employed in analogy with brain crude mitochondrial
fractions often used for uptake assays. The temperature-
independent [3H]Glu accumulation seems to correspond,
at least in part, to the portion insensitive to Triton X-100
and replacement with ChCl, whereas its physiological
significance is unclear. Although [3H]Glu accumulation
was not significantly inhibited by all agonists tested for
iGluRs and mGluRs at 30 C, the possible binding to
particular subtypes of GluRs expressed in rat testis at 2 C
has not been ruled out so far. Pharmacological profiling
could be made easier than that in the present analysis when
[3H]Glu accumulation is determined under experimental
conditions exclusively favorable for the temperature-
dependent portion in the rat testis. In the CNS, five
subtypes of GluTs show distribution profiles diﬀerent from
each other (Tanaka et al. 1997, Danbolt 2001). Lethal
spontaneous seizures are seen in mice with the gene for
GLT-1 knocked out (Tanaka et al. 1997), while GLAST-
mutant mice show only slight motor discoordination
without mortality (Watase et al. 1998). The present
findings that GLAST, GLT-1 and EAAT5 exhibited
diﬀerent localization profiles in the rat testis as seen in
the CNS argue in favor of the idea that each GluT sub-
type could play a role peculiar to individual subtypes
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in the mechanisms associated with the maintenance of
integration and function of diﬀerent cells located in the rat
testis.
In addition to the aforementioned five diﬀerent sub-
types of GluTs, this study has also demonstrated the
expression of mRNA for particular iGluRs and mGluRs
in the rat testis as revealed by RT-PCR. A previous study
claims functional expression of both mGluR1 and
mGluR5 for group I mGluR subtype in the rat testis
(Storto et al. 2001), while the first evidence has been
presented in the present investigation for the expression of
additional mRNA of both mGluR2 and mGluR3 for the
group II subtype as well as of both mGluR6 and mGluR8
for the group III subtype in the rat testis respectively,
without expression of that of both mGluR4 and mGluR7
for the group III subtype. The expression of NR1,
GluR2/3 and mGluR2/3 proteins has already been shown
in the rat testis (Gill et al. 2000, Gill & Pulido 2001),
whereas the present article seems to be the first direct
evidence for the expression of mRNA of particular
iGluRs, including NR2A-C, NR2D, GluR7, KA1 and
KA2 subunits in the rat testis. Although the functionality
of these particular GluR subunits demonstrated here
should undoubtedly await further evaluation in future
studies, the data cited above all argue in favor of the
hypothesis that Glu could serve as a signal mediator
through particular iGluR, mGluR and GluT subtypes
expressed in the rat testis. For glutamatergic signal trans-
duction, nevertheless, expression of VGLUTs as well as
exocytotic release of Glu should be studied in the testis
in vivo and in vitro as shown in cultured osteoblasts (Hinoi
et al. 2001). Functional expression of molecular machin-
eries required for glutamatergic signaling in the brain
should be demonstrated in the rat testis before drawing any
final conclusion.
It thus appears that Glu may be one of the endogenous
substances aﬀecting function and integrity through recep-
tors and transporters in the rat testis. A search for receptor
ligands as well as transporter modulators would be of great
benefit for the discovery and development of drugs useful
for the therapy and treatment of a variety of endocrino-
logical disorders associated with testicular malfunction in
human beings.
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